ArticleArthritis research & therapy2012

Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.

Jack Hutcheson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.